As we navigate through the midpoint of the decade, the long-term outlook for the pharmaceutical quality sector has never been more robust. According to current GMP Market Projections, the industry is expected to sustain a compound annual growth rate (CAGR) of approximately 6.8%, potentially reaching a market valuation of over USD 2.64 billion by 2032. This sustained expansion is...